title: Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome.
authors.forename: Michael B
authors.initials: MB
authors.lastname: Sprakes
authors.forename: P John
authors.initials: PJ
authors.lastname: Hamlin
authors.forename: Alexander C
authors.initials: AC
authors.lastname: Ford
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000032:analysis; D016022:Case-Control Studies; D015897:Comorbidity; D003937:Diagnosis, Differential; D005243:Feces / Q000737:chemistry*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis* / Q000453:epidemiology; D043183:Irritable Bowel Syndrome / Q000175:diagnosis* / Q000453:epidemiology; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis*; D008297:Male; D011237:Predictive Value of Tests; D012008:Recurrence; D012016:Reference Values; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex